Roche Holding Ltd ROG.ZU

Roche Holding AG is a Swiss multinational healthcare company. Founded in 1896, the firm is based in Basel, Switzerland, and serves a worldwide customer base. Roche is dedicated to improving the lives of patients living with MS, cancer and rare diseases.

Roche Holding operates through two divisions, namely Pharmaceuticals and Diagnostics. The firm has been working in the area of pharmaceuticals since its inception over a century ago. In 1968 Roche created a diagnostics department, not only developing diagnostic tests and automatic analysers, but also setting up laboratories equipped to perform clinical analyses for hospitals and physicians. Roche is focused on the move towards personal healthcare and has acquired key players in life science research, gene sequencing and tissue diagnostics. In 2009, the firm acquired biotech pioneer Genentech in a $46.8bn deal.

Stock for Roche Holding trades on the SIX Swiss Exchange under the ticker ROG.ZU. The company’s stock has been listed on this exchange since September 1995. Roche Holding is the parent company to many subsidiaries, including Ventana Medical Systems, Inflazome Ltd., Roche Diagnostics Corporation, Genmark Diagnostics, Chugai Pharmaceutical Co., Genentech, Syntex, Intermune, Inc., Spark Therapeutics and several others.

Monitor the ROG.ZU share price by adding it to your eToro watchlist.